COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSES USING REAL WORLD DATA FROM BRAZILIAN HEALTH CARE INSURANCE COMPANIES IN THE TREATMENT OF IRON DEFICIENCY IN PATIENTS WITH HEART FAILURE

被引：0

作者：

Campagnaro, M. ^{[1
]}

Malard, W. ^{[2
]}

Clemente, V ^{[3
]}

Nunes, A. A. ^{[4
]}

机构：

[1] CSL Vifor, Sao Paulo, SP, Brazil

[2] CSL Vifor, Ribeirao Preto, SP, Brazil

[3] CSL Vifor, Sao Paulo, SP, Brazil

[4] Univ Sao Paulo, Ribeirao Preto, SP, Brazil

来源：

VALUE IN HEALTH | 2023年 / 26卷 / 12期

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

EE467

引用

页码：S141 / S141

页数：1

共 50 条

[1] FERRIC CARBOXYMALTOSE IN THE TREATMENT OF IRON DEFICIENCY IN PATIENTS WITH HEART FAILURE FROM THE PERSPECTIVE OF PRIVATE HEALTH CARE SYSTEM: COST-EFFECTIVENESS ANALYSIS AND BUDGET IMPACT IN BRAZIL
Campagnaro, M.
Picoli, R. M.
Castelano, N.
Clemente, V
Serna, Ramirez de Arellano A.
VALUE IN HEALTH, 2023, 26 (12) : S111 - S111
[2] Ferric carboxymaltose for patients with heart failure and iron deficiency in Italy: cost-effectiveness and budget impact
Rognoni, Carla
Gerzeli, Simone
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (13) : 1099 - 1110
[3] Cost-effectiveness analyses using real-world data: an overview of the literature
Bowrin, Kevin
Briere, Jean-Baptiste
Levy, Pierre
Millier, Aurelie
Clay, Emilie
Toumi, Mondher
JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (06) : 545 - 553
[4] COST-EFFECTIVENESS OF FERRIC CARBOXYMALTOSE IN PATIENTS WITH IRON DEFICIENCY AND CHRONIC HEART FAILURE IN AUSTRIA
Walter, E.
Bauer, M.
Ressl, S.
VALUE IN HEALTH, 2015, 18 (07) : A392 - A392
[5] Real-world eligibility and cost-effectiveness analysis for empagliflozin in patients with heart failure
Kim, E. S.
Park, S. K.
Youn, J. C.
EUROPEAN HEART JOURNAL, 2022, 43 : 972 - 972
[6] Real-World Eligibility and Cost-Effectiveness Analysis for Empagliflozin in Patients with Heart Failure
Kim, E.
Kim, K.
Park, S.
Youn, J.
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S82 - S82
[7] Cost-Effectiveness Analysis of Implantable Cardiac Devices in Patients With Systolic Heart Failure: A US Perspective Using Real World Data
Lu, Xiaoxiao
Paly, Victoria F.
Shah, Dhvani
Tsintzos, Stelios
CIRCULATION, 2019, 140
[8] Cost-effectiveness analysis of implantable cardiac devices in patients with systolic heart failure: a US perspective using real world data
Shah, Dhvani
Lu, Xiaoxiao
Paly, Victoria F.
Tsintzos, Stelios, I
May, Damian M.
JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (07) : 690 - 697
[9] COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF BETA BLOCKERS FOR CHRONIC HEART FAILURE PATIENTS IN SPAIN
Espallardo, O.
Polanco, C.
VALUE IN HEALTH, 2009, 12 (07) : A323 - A323
[10] NATIONWIDE ANNUAL HEALTH INSURANCE TREATMENT COST OF HEART FAILURE IN HUNGARY: COST OF ILLNESS STUDY BASED ON REAL WORLD DATA
Endrei, D.
Sebestyen, A.
Gazso, T.
Molics, B.
Acs, P.
Habon, T.
Boncz, I
VALUE IN HEALTH, 2019, 22 : S542 - S542

← 1 2 3 4 5 →